UBS Group AG - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$7,508
+83322.2%
16,501
+126830.8%
0.00%
Q2 2023$9
+50.0%
130.0%0.00%
Q1 2023$6
-99.9%
13
-100.0%
0.00%
Q4 2022$9,075
+126.9%
29,275
+382.1%
0.00%
Q3 2022$4,0000.0%6,073
+13.7%
0.00%
Q2 2022$4,0005,342
+88933.3%
0.00%
Q1 2022$06
-40.0%
0.00%
Q4 2021$0100.0%0.00%
Q3 2021$010
-41.2%
0.00%
Q2 2021$0170.0%0.00%
Q1 2021$0170.0%0.00%
Q4 2020$0170.0%0.00%
Q3 2020$0170.0%0.00%
Q2 2020$0170.0%0.00%
Q1 2020$017
-32.0%
0.00%
Q4 2019$025
+25.0%
0.00%
Q3 2019$0200.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q3 2022
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders